Pear Therapeutics OverviewPear Therapeutics Cost of Revenue
Cost of Revenue analysis for PEAR.
Quarterly Cost of Revenue
$1.75M
↓ 66.65% YoY
As of Dec 31, 2022
Annual Cost of Revenue (TTM)
$8.18M
↓ 9.56% YoY
Trailing 12 months ending Dec 31, 2022
Pear Therapeutics OverviewCost of Revenue analysis for PEAR.
As of Dec 31, 2022
Trailing 12 months ending Dec 31, 2022